Improving shared decision-making around the use of disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer
Description: NARRATIVE Patients with rheumatoid arthritis (RA) have an increased incidence of cancer, especially lymphoma and lung cancer, compared to the general population and to date relatively little is known about the safety of standard immunosuppressives for RA in patients with active or recently (< 5 years since diagnosis) diagnosed cancer. Little is also known about how to support decision-making for these patients who have at least two major comorbid conditions and may be under the care of multiple different specialists. The central focus of this proposal is to advance the evidence-base around use of immunosuppressive medications among patients with RA who have active or recently diagnosed cancer and to provide a foundation for shared decision making to ensure alignment between treatment decisions and the values, goals, and preferences of individual patients.
Funding type: career_development
Funder scheme: K23
Start date: 2022-07-01
End date: 2027-06-30
Investigator: NAMRATA SINGH (lead)
Institution: University of Washington
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Funded outputs count: 63
Funder award ID: K23AR079588
OpenAlex ID: G9000866296
